PharmaLectures.com

Courses › Pharma sales skills and selling across cultures › Selling to Japanese and Korean buyers when you are from Brazil and Latin America: how they decide, what loses the deal

Selling to Japanese and Korean buyers when you are from Brazil and Latin America: how they decide, what loses the deal

Your team closes Japanese and Korean pharma deals instead of losing them to silence

  • 8 audio modulesthree lengths each
  • 1 h 20 min to 6 h 40 minbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Brazil and Latin America saleswho it is written for

Why this training matters

Your representative flies from São Paulo to Tokyo, hands over a business card, and takes a polite silence for a yes. The proposal then sits for months with no answer. The trip, the preparation and the quarter's pipeline all go to waste.

What changes after this course

Your team reads the room, finds the person who signs, and wins agreement across the buyer's team before the final presentation. You hold a certificate per learner and a per-person training record that shows who is ready for Tokyo and Seoul.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your representatives stop guessing why a promising conversation went cold. They find who signs in Tokyo or Seoul and who only evaluates. They do the groundwork with the Japanese team, so the ringi, the circulated approval document, reaches the committee with everyone already in agreement.

A business card exchange stops being a risk. Your team walks into a first meeting knowing where to sit, who to address first, and what a long silence means. Their technical data carries the detail that Japanese and Korean pharmaceutical buyers check before they trust a supplier.

Follow-up gets a rhythm. Your account managers stop pressing for a signature, wait through the company seal approval in Japan, and answer Korean questioning with proof of commitment. They catch the first sign of disagreement and adjust the terms before the buyer quietly leaves.

After hours, the dinner and the site visit stop being traps. Your people know which remarks end a relationship and which repair one, so a signed letter of intent stays signed, even when something goes wrong in the room.

Who needs this training

  • Export Sales Representative, Latin America

    You fly to Tokyo for a major pitch and the room goes quiet. This course shows you what the silence means, so you stop pushing for a close that offends the senior buyer.

  • Business Development Lead, Brazil

    A Korean contact is warm and enthusiastic for months. You learn to check early whether that person can approve a vendor contract, before the time is spent on the wrong desk.

  • Regional Pharma Sales Director

    Late-stage deals in Asia keep slipping over etiquette and rushed follow-up emails. You send a team that protects the deal, and you have a training record to show it.

  • Account Manager, Asia-Pacific Markets

    You meet Korean teams regularly. You learn to spot the small non-verbal signs of disagreement with your pricing in the meeting itself, while you can still change the offer.

Roles: Owner, CEO and board, Business development and export sales, Marketing and communications

Businesses: every kind of pharma company

Countries: Brazil and Latin America

Selling into: Asia Pacific

Courses are in English. Other languages on request.

After this course your people can

  1. Read the pauses in a Japanese meeting and spot a hidden objection before it stalls the deal.
  2. Exchange business cards with the right posture and order for the rank of each person present.
  3. Identify who evaluates, who influences and who signs in a Korean pharmaceutical company.
  4. Prepare the groundwork with Japanese stakeholders so the approval document circulates smoothly before the final committee.
  5. Format technical proposals to the level of detail that Japanese and Korean buyers check.
  6. Set a follow-up schedule that fits the buyer's approval timeline without pushing.
  7. Recover from a cultural misstep at a business dinner or site visit before it costs the deal.

What the company gets

  • Your travel budget produces signed contracts instead of polite silences that never turn into orders.
  • Your team earns the trust of Japanese and Korean pharmaceutical buyers from the first meeting, because each person knows the customs of the room.
  • Proposals reach the people who sign and move through approval in Japan and Korea without stalling at an overlooked evaluator.
  • Every learner has a certificate and a training record, so you can show who is ready before you book the next flight.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 8 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing1 h 20 min10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard3 h 20 min25 min a module, for regulatory, quality and business-development staff
Expanded6 h 40 min50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Business development and export salesBriefing1 h 20 min
Owner, CEO and boardBriefing1 h 20 min
Marketing and communicationsBriefing1 h 20 min

Course outline: 8 modules

8 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Adapt your pitch to how Japanese buyers build harmony before they look at price

    • Why a Japanese buyer wants harmony settled before your price is ever read.
    • How to tell the moment to stop presenting and start listening, so the room keeps opening up to you.
    • What to do when pushing for a quick answer has frozen the talks.
  2. 2Shape your pitch around what Korean corporate teams expect from a supplier

    • What to do when a Korean buyer tests your loyalty and reliability before reading the proposal.
    • How to tell from the senior executive's mood whether your presentation is landing.
    • The reporting line in a Korean pharma company that decides who speaks first in the room.
  3. 3Open your first meeting with Japanese pharma buyers and read the room

    • How to hand over your business card so the senior buyer feels respected from the first minute.
    • The opening remark that acknowledges rank without making you sound servile.
    • Why some small-talk topics build rapport and others end the meeting early.
  4. 4Run Korean pharma sales meetings and read answers that never say no

    • When to bow and when to shake hands, based on the seniority of the person across the table.
    • How to read an indirect answer so you know exactly where your proposal stands.
    • The small non-verbal signs that tell you a Korean buyer disagrees with your terms.
  5. 5Map who evaluates, who influences and who signs in Japan and Korea

    • How to find the person who signs the contract and tell them apart from the one who evaluates.
    • The groundwork that gets the whole Japanese team agreeing before the committee meets.
    • Why a junior evaluator in Korea matters to how your offer reaches senior decision makers.
  6. 6Close Japanese deals by working with ringi approval and the company seal

    • How to format technical data so it meets the Japanese demand for complete precision.
    • What the company seal approval means for your timeline and your follow-up dates.
    • Why a hard closing push makes a Japanese pharma buyer walk away.
  7. 7Secure Korean pharma contracts through the questioning and the follow-up

    • How to prepare for the intense questioning Korean teams use to test your commitment.
    • When a third-party introduction frees a stalled negotiation, and when it does not.
    • The follow-up rhythm that shows dedication without tipping into disrespect.
  8. 8Spot the missteps that kill Asian pharma deals before they happen

    • Why attention to detail in your slide deck matters to a Japanese buyer.
    • The business dinner mistakes that can cancel a letter of intent already signed.
    • How to recover when you offend a senior executive during a site visit.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

8 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 1 h 20 min in the briefing length and 6 h 40 min in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Brazil and Latin America sales. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 72 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team